IP Library › Assignment 025546/0686
Patent Assignment
Reel/Frame 025546/0686

Merger

Recorded: 2010-12-21 Pages: 5
Assignor
TRUBION PHARMACEUTICALS, INC.
Executed: 2010-10-28
Assignee
EMERGENT PRODUCT DEVELOPMENT SEATTLE, LLC
2401 FOURTH AVENUE, SUITE 1050, SEATTLE, WASHINGTON, 98121
Covered Property (1)
Materials and Methods for Improved Immunoglycoproteins
Patent: 7,846,434 →
Application: 12/082,497 →
Publication: US 2009/0041765
Related Assignments (4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Dec 3, 2008
From: THOMPSON, PETER ARMSTRONG; BAUM, PETER ROBERT; ESPLING, ERIK STEPHEN
To: TRUBION PHARMACEUTICALS, INC.
Reel/Frame 021920/0279 →
Change of Name Jul 18, 2016
From: EMERGENT PRODUCT DEVELOPMENT SEATTLE, LLC
To: APTEVO RESEARCH AND DEVELOPMENT LLC
Reel/Frame 039382/0985 →
Security Interest Feb 7, 2019
From: APTEVO THERAPEUTICS INC.; APTEVO BIOTHERAPEUTICS INC.; APTEVO RESEARCH AND DEVELOPMENT LLC
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 048270/0813 →
Release of Security Interest Mar 6, 2020
From: MIDCAP FINANCIAL TRUST, AS AGENT
To: APTEVO THEAPEUTICS INC.; APTEVO BIOTHERAPEUTICS LLC; APTEVO RESEARCH AND DEVELOPMENT LLC
Reel/Frame 052039/0258 →